A federal appeals court appeared poised Monday to rule against a Trump administration rule requiring that drug manufacturers include the price of prescription drugs in television ads.

A three-judge panel for the U.S. Court of Appeals for the D.C. Circuit, appointed by presidents from both parties, heavily questioned Department of Justice attorney Ethan Davis on how the requirement is tied to the Department of Health and Human Services’ administration of Medicaid and Medicare.